2 news items
Benchmark Upgrades BioLife Solns to Buy, Announces $25 Price Target
BLFS
13 May 24
Benchmark analyst Robert Wasserman upgrades BioLife Solns (NASDAQ:BLFS) from Hold to Buy and announces $25 price target.
Jefferies Initiates Coverage On BioLife Solns with Buy Rating, Announces Price Target of $22
BLFS
4 Apr 24
Jefferies analyst Matthew Stanton initiates coverage on BioLife Solns (NASDAQ:BLFS) with a Buy rating and announces Price Target of $22.
- Prev
- 1
- Next